
Sign up to save your podcasts
Or


In this episode of FEG’s Insight Bridge Podcast, Greg Dowling speaks with Peter Kolchinsky, Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmune disorders. Peter shares RA Capital’s investment approach, which emphasizes patience, rigor and selectiveness across healthcare and life science sectors.
You can find every episode of FEG Insight Bridge podcasts in one place and sign up to receive our other publications here.
By FEG Investment Advisors5
44 ratings
In this episode of FEG’s Insight Bridge Podcast, Greg Dowling speaks with Peter Kolchinsky, Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmune disorders. Peter shares RA Capital’s investment approach, which emphasizes patience, rigor and selectiveness across healthcare and life science sectors.
You can find every episode of FEG Insight Bridge podcasts in one place and sign up to receive our other publications here.

229,286 Listeners

1,361 Listeners

3,079 Listeners

1,929 Listeners

1,094 Listeners

2,322 Listeners

5,149 Listeners

87,740 Listeners

796 Listeners

2,026 Listeners

324 Listeners

1,299 Listeners

1,352 Listeners

274 Listeners

407 Listeners